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In all organisms, genetic information is stored in DNA and RNA. Both of these macromolecules
are damaged by many exogenous and endogenous events, with UV irradiation being one of the
major sources of damage. The major photolesions formed are the cyclobutane pyrimidine dimers
(CPD), pyrimidine–pyrimidone-(6-4)-photoproducts, Dewar valence isomers and, for dehydrated
spore DNA, 5-(a-thyminyl)-5,6-dihydrothymine (SP). In order to be able to investigate how
nature’s repair and tolerance mechanisms protect the integrity of genetic information,
oligonucleotides containing sequence and site-specific UV lesions are essential. This tutorial review
provides an overview of synthetic procedures by which these oligonucleotides can be generated,
either through phosphoramidite chemistry or direct irradiation of DNA. Moreover, a brief
summary on their usage in analysing repair and tolerance processes as well as their biological
effects is provided.
1. Introduction
Nucleic acids (RNA and DNA) are used by organisms for
storage of genetic information, which is encoded in the
sequences of the four nucleobases adenine, cytosine, guanine
and thymine (and uracil in RNA). UV-light is one of the most
frequent exogenous influences that harm these nucleic acids, in
particular UV-C (o280 nm).1,2 However, longer wavelength
UV light is of higher biological relevance due to the absorption
of UV-C by ozone in the upper parts of the atmosphere.2
Dimerization through electrocyclic ring formation between
two pyrimidines is the most important photoreaction caused
by UV-B and UV-C irradiation of DNA in cells (Scheme 1).
Cyclobutane pyrimidine dimers (CPD lesions) 1 and
pyrimidine–pyrimidone-(6-4)-photoproducts (6-4 lesions) 4,
caused by these reactions, and their secondary products, the
Dewar valence isomers (Dewar lesion) 5, are the most
abundant UV lesions and are responsible for much of the
destructive effect of UV light. In the formation of CPD lesions
the two C5QC6 double bonds react in a [2p + 2p]
cycloaddition, whereas a cycloaddition between the C5QC6
double bond of the 50 nucleoside and the C4 carbonyl group of
the 30 nucleoside, named Paterno´–Bu¨chi reaction, leads to (6-4)
lesions. The harmful effects of UV-A, which does not directly
affect the nucleobases, are due to the excitation of photo
sensitizers and further triplet energy transfer resulting in the
formation of CPD lesions.
It is also known that UV-C radiation can cause various
reactions such as the photohydration of pyrimidines and direct
photooxidation of guanine.1 Adenine, a purine base, also
shows photoreactivity, with involvement in cycloaddition
reactions under UV-C irradiation. The C5QC6 double bond
of a 30 side adenine can either react with the 50-side C5QC6
double bond of thymine or with the N7QC8 double bond of
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adenine.3,4 Secondary reactions result in two different types of
AA lesions and, by ring expansion, in the TA lesion.
In addition to the above named lesions a unique dimer
is created if bacterial spores are exposed to UV-C,
5-(a-thyminyl)-5,6-dihydrothymine, also known as the spore
photoproduct (SP) 2.5 This lesion is formed due to
complexation of the DNA with small acid soluble proteins
(SASPs), a high level of dehydration and the considerable
amounts of dipicolinic acid present in spores. This
environment significantly changes the photochemistry of
DNA and the other photolesions are no longer formed.
Replicative polymerases cannot replicate through UV
induced dimers, which therefore stop replication. However,
nature has developed several pathways to handle this situation
in order to avoid apoptosis. Base excision repair (BER),
nucleotide excision repair (NER), photolyase-induced repair
and trans lesion synthesis (TLS) are the most important of these.
In BER the N-glycosidic bond between a damaged base and
its corresponding deoxyribose is hydrolysed via a special DNA
glycosylase.6,7 Subsequent processes involving nucleotide
insertion and ligation complete the repair. BER is
predominantly responsible for the removal of oxidative
lesions and deaminated bases, but there are also prokaryotes
and lower eukaryotes known in the literature with glycosylases
specific for e.g. the CPD lesion.8
NER is a repair pathway utilised for many different DNA
lesions in prokaryotes and eukaryotes.9,10 Even though
the proteins involved vary significantly between species, the
general mechanism is similar in all organisms. Initially the
lesion is recognised and excised together with several
surrounding bases. The resulting gap is then filled up by a
polymerase and a ligase seals the nick. There are, depending on
the organism, many enzymes involved (from o10 in
prokaryotes to at least 30 in eukaryotes such as yeast and
humans) and for human NER the picture is not complete.
However, it is clear that NER is a very important repair
pathway for UV induced lesions, because the lack of a NER
enzyme causes Xeroderma Pigmentosa, a hereditary disease
which results in a high skin cancer rate and increased UV-light
sensitivity. The (6-4) and Dewar lesions seem to be good
substrates for NER, whereas for the CPD lesions other
pathways such as TLS and photolyase-induced repair seem
to be more important.
Photolyases are monomers with a molecular weight of about
55–60 kDa and a catalytic FADH cofactor which injects
electrons for the photoreversion of the dimers to the
corresponding undamaged nucleotides.11 A second cofactor
such as 5,10-methylenetetrahydrofolate (MTHF) or 8-hydroxy-
7,8-didemethyl-5-deazariboflavin (8-HDF) acts as a light-
harvesting photoreceptor to improve the quantum yield.
There are two types of photolyases, namely those that repair
CPD lesions and those that repair (6-4) lesions and their
Dewar valence isomers. Surprisingly and still unexplainable,
experiments show that T(Dew)T is not repaired by these
enzymes, or if so, with an extraordinary low quantum
yield.12,13 Moreover, not all organisms, (e.g. higher eukaryotes
like humans) are able to perform this type of repair.
Aside from the light driven photolyases, which are related to
cryptochromes, there is one light independent photoproduct
Scheme 1 Depiction of the four main pyrimidine–pyrimidine photo-
lesions. 1: Cyclobutane pyrimidine dimer, 2: spore photoproduct, 4: (6-4)
photoproduct, 5: Dewar valence isomer of 4.
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repair enzyme, the spore photoproduct lyase, which is a radical
S-adenosylmethionine (SAM) dependent enzyme.14 The SP
lyase uses an iron–sulfur cluster ([4Fe–4S]) and SAM as
cofactors to yield a 50-deoxyadenosyl radical and finally
repair the SP.
The repair and formation of these lesions was and is still a
key objective in scientific research, and as synthetic lesions and
lesion analogues are powerful tools to investigate these
pathways, chemistry hand in hand with biology is necessary
to solve these questions of the nature of life.
2. Cyclobutane pyrimidine dimers
CPDs are the most abundant lesions resulting from UV irradia-
tion and the [2p+2p] cycloaddition principally gives rise to three
different configural isomers of the four-membered ring. However,
due to the fixed conformation (anti relative to the glycosidic bond)
of a DNA double helix, the cis-syn-isomer is almost exclusively
formed. CPDs appear in vivo between all pyrimidine pairs, but
not in equal ratios. The formation trends are 50-T(CPD)T-30 >
50-T(CPD)C-30 > 50-C(CPD)T-30 > 50-C(CPD)C-30, where the
yield of T(CPD)T is about three times higher than T(CPD)C.15,16
It is worth mentioning that the NH2 substituents of CPDs are not
stable and deaminate spontaneously to form uracil-containing
secondary photoproducts in an hour timescale.17,18
The first synthesis of T(CPD)T (Scheme 2), including
incorporation into DNA as a phosphoramidite, was reported
by Taylor et al. in 1987.19 The dinucleotide 8 was synthesized
by coupling of the thymidine phosphoramidite 6 and the
30-silyl protected thymidine 7 with tetrazole as activator,
followed by oxidation with iodine to afford the desired
phosphorus(V) species. After deprotection of the 50-OH,
irradiation with Pyrex-filtered UV light in the presence of
acetophenone as triplet sensitizer led to the partially
protected CPD 9 as well as its configural isomers. Both
cis-syn CPD diastereomers, epimeric at phosphorus, were
separated by HPLC. Protection of 9 with DMTCl, followed
by removal of the tert-butyldimethylsilyl group and reaction
with chloro(methoxy)(morpholinyl)phosphine led to the
phosphoramidite building block 11. The oligonucleotide,
synthesized on controlled pore glass, was deprotected and
cleaved from the solid support with a two step protocol,
necessary due to the removal of the methoxy group at the
phosphorus.
The trans-syn isomer was incorporated in DNA with a
similar strategy.20 The conversion of 10 was done with a
modified procedure including reversal of the tritylation and
desilylation steps and replacement of the morpholinyl-
phosphoramidite by the more reactive diisopropylaminopho-
sphoramidite to yield 12.
A more elegant synthesis based on cyanoethyl and levulinyl
protecting groups was developed by Ohtsuka and coworkers.21
The cyanoethyl protecting group on the phosphate allows the
use of a one step protocol for deprotection and cleavage.
Since the levulinyl group can be removed in the presence of a
cyanoethyl protected phosphate, it was also possible to
synthesize T(CPD)T dithionate building blocks. These
dithionate substrates, as well as CPD lesions, with methyl
protection at the phosphorus, were used to clarify the binding
mode of T4 endonuclease V, a CPD specific glycosylase.
Scheme 2 Synthesis of cis-syn and trans-synCPD lesion 11 and 12: (a) 1H-tetrazole, MeCN then I2 in H2O, pyridine; (b) e.g. 80%HOAc; (c) H2O,
MeCN, acetophenone, hu (450WHg-lamp); (d) DMTCl, pyridine; (e) TBAF, THF,HOAc; (f) morpholine, CH3OPCl2, DIEA; (g) HCl, acetic acid;
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These studies showed that the enzyme interacts strongly with
its substrate in the minor groove of DNA, in agreement with a
later crystal structure.8,22
The usage of a phosphodiester bridged photolesion requires
protection as illustrated, which results in additional reaction
steps and leads to the formation of an additional stereocenter
at the phosphorus resulting in the necessity of HPLC to
separate the diastereomers.
To overcome these problems Carell et al. developed the
synthesis of a bio-isosteric formacetal linked T(CPD)T.23 For
this purpose the 50-O-acetyl-30-O(methylthiomethyl)-protected
thymidine 13 was coupled with 14 to give the formacetal
bridged dinucleotide 15 (see Scheme 3). Irradiation of 15 in a
Pyrex device resulted in a mixture of the cis-syn 16 and the
trans-syn isomers. In this reaction mixture only the formacetal
linked cis-syn T(CPD)T is insoluble in acetone, which allows
the purification of the desired lesion in multigram scale simply
by washing off the precipitate. After deprotection and two-step
conversion to the DMT protected phosphoramidite 17, solid
phase synthesis of oligonucleotides under standard conditions
is possible. The U(CPD)U lesion was synthesized using the
same route. For these uridine derivatives normal deprotection
of oligonucleotides with conc. NH4OH resulted in opening of
the C(4)–N(3) bond, but the use of saturated ammonia in
anhydrous methanol allowed the preparation of U(CPD)
U-containing oligonucleotides in excellent yields.23
The formacetal bridged T(CPD)T was used, for example,
in the first reported crystal structure of a photolyase
(Anacystis nidulans CPD photolyase) in complex with UV
damaged DNA.24 The oligonucleotide is bent by 501 and the
lesion is flipped into the active side of the enzyme, where it was
split into two thymidines by the synchrotron radiation at
100 K. This structure mimics a substrate during light-driven
DNA repair in which back flipping of the thymines has not yet
occurred, which demonstrates that substitution of the phospho-
diester group by an uncharged, hydrophobic formacetal does
not affect binding properties significantly.
As mentioned previously, higher eukaryotes (e.g. humans)
are unable to perform this type of repair and use different
pathways such as transcription-coupled repair (TCR), which is
a very efficient NER subpathway, to remove this type of
lesion.25 Cramer and co-workers used formacetal bridged
T(CPD)T for structure-based investigation of the mechanism
of the first step in eukaryotic TCR, CPD-induced stalling of
RNA polymerase (Pol) II.26 The lesion slowly passes the bridge
helix (Fig. 1) and enters the active site where the 50-thymine of
the CPD then directs uridine misincorporation into mRNA,
which blocks translocation. The inaccessibility of the lesion in
the stalled complex and the unchanged conformation of the
polymerase indicate nonallosteric recruitment of other TCR
proteins and excision of the damaged oligonucleotide in the
presence of Pol II.
Aside from these examples, oligonucleotides containing
synthetic T(CPD)T lesions are extensively used in studies to
clarify UV lesion repair, particularly as the T(CPD)T phos-
phoramidite is commercially available. However for special
requirements, particular UV lesions such as a T(CPD)T with
an open backbone need to be synthesized.27–29 For this
purpose, CPD phosphoramidites, such as 18, where the internal
phosphate is replaced by a base cleavable group such as a
Scheme 3 Synthesis of T(CPD)T with formacetal backbone 17,
(a) NIS, TfOH, THF; (b) hu (150 W Hg-lamp), acetone; (c) NH4OH,
rt, 12 h; (d) DMTCl, pyridine, DIEA; (e) (NCCH2CH2O)PN(i-Pr)2(Cl),
DIEA, THF.
Fig. 1 Pol II elongation complex structures with T(CPD)T in the
template. Protein is in gray, the bridge helix in blue, and the lesion is
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phthalic acid ester or a diisopropylsilyl group can be used
(see Scheme 4).27,29 This group is removed during cleavage
from the solid support and removal of the other protecting
groups to give compounds as 19 in the duplex. In assays with
photolyases and for studying electron transfer processes the
CPD 19 is converted to two thymidines, resulting in an easily
detectable strand break.28
3. Pyrimidine–pyrimidone-(6-4)-photoproducts
and Dewar valence isomers
As mentioned previously, (6-4) lesions are also formed by a
photochemical formal [2p + 2p] cycloaddition. Here, the
C5QC6 double bond of the 50 nucleoside reacts, possibly via
a triplet state, with the C4 carbonyl group of the 30 nucleoside.
In the case of two thymidines, this occurs in a Paterno´–Bu¨chi
reaction to give an oxetane. This oxetane, which is not stable
above 80 1C, reacts further by ring opening to give the (6-4)
photoproduct. In the case of a 30 cytidine the reaction occurs
from an imine tautomer with formation of a azetidine
intermediate. (6-4) Lesions occur more efficiently on TC
rather than TT sites. Reactions with a 50 cytidine are also
possible, however they are the least frequent.30
On exposure to additional UV-A irradiation, (6-4) lesions
undergo a formal 4p electrocyclic rearrangement to give the
corresponding Dewar valence isomers, which are similar in
many aspects to (6-4) lesions. Dewar lesions are, in fact, at least
as important as their parent lesions as they are more abundant
than (6-4) lesions in DNA of cells irradiated with simulated or
natural sunlight.16,31
The first reported (6-4) lesion in oligonucleotides was made
using a synthetic approach based on a levulinyl cyanoethyl
protecting group strategy (Scheme 5).32 Coupling of the 50-O-
DMT-cyanoethylphosphoramidite 20 with the 30-O-Lev-
protected cytidine 21, oxidation of the bridging phosphite
with iodine and deprotection with acetic acid afforded the
T–T-dinucleotide 22. Irradiation with UV-C light from
germicidal mercury lamps under anaerobic conditions led to
a mixture of photoproducts from which the (6-4) dinucleotide
23 was isolated in yields of about 15% in the best cases.
The 50-hydroxyl group was converted into the DMT
protected species and the 30-OH of this compound was
then deprotected with hydrazine and converted to the
phosphoramidite 24. Due to high steric hindrance,
Scheme 4 Formation of T(CPD)T with open backbone during
cleavage of oligonucleotides from solid support.
Scheme 5 Synthesis of T(6-4)T and T(Dew)T building blocks 24 and 26. (a) 1H-tetrazole; (b) I2, H2O, pyridine; (c) 80% HOAc; (d) UV (254 nm),
20% MeCN; (e) DMTCl, pyridine; (f) NH2NH2H2O, pyridine, 5 min; (g) (NCCH2CH2O)PN(i-Pr)2Cl, DIEA; (h) UV (>280 nm); (i) DMTCl,
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the C(5)–OH needs no protection for solid phase DNA
synthesis.
The strategy of levulinyl cyanoethyl protection was also used
by Iwai et al. to synthesize the T(6-4)C and the T(Dew)T
phosphoramidites.33,34 In the case of the T(6-4)C building
block the C(5)–NH2 was protected with a DMT-group before
coupling of the 50-thymidine and the 30-cytidine, followed by
deprotection then irradiation. HPLC separation of the T(6-4)C
and three additional reaction steps yielded the desired phos-
phoramidite. It was found that in standard solid phase synth-
esis with this compound, acetylation of the exocyclic amino
group occurs during the capping step, which makes it necessary
to omit this step after coupling of the (6-4) unit. For the
synthesis of the Dewar phosphoramidite the 50-unprotected
T(6-4)T 23 was prepared as mentioned previously.32 Irradia-
tion with Pyrex filtered UV light, followed by HPLC purifica-
tion yielded the partially protected T(Dew)T 25 which was
converted to the phosphoramidite 26 as previously.
In addition to the natural lesions, modified (6-4) and Dewar
lesions have been used. For example, Fourrey and coworkers
used T (6–4)s5T, produced by irradiation of 50-O-thymidylyl-4-
thiothymidine, for mechanistic studies, which indicated that
repair by (6-4) photolyases proceeds via a oxetane such as
azetidine.35 Furthermore, a synthetic route to the phosphor-
amidite of this thio analogue is available.36
Although the toolset for investigation of (6-4) and Dewar
repair with synthesized lesions and oligonucleotides is
available, this approach is used in very few cases, as
synthesis of the phosphoramidite building blocks is lengthy,
difficult and the efficiency unsatisfactory. Most biological
studies are done with lesion-containing DNA produced by
direct irradiation of oligonucleotides. The unique absorption
of (6-4) lesions at about 320 nm enables detection and isolation
of the desired oligonucleotides even from complicated
irradiation mixtures and conversion to the Dewar isomers is
typically clean and complete. Early experiments were only able
to isolate short oligonucleotides containing T(6-4)T such as
T(Dew)T.37,38 However, careful choice of the nucleotide
sequence and optimized anaerobic irradiation conditions
enable the irradiation of 18mers without difficulty in high
purity and satisfactory yields.39 The limitation in length can
furthermore be overcome by ligating short irradiated
oligonucleotides into larger sequences.40
With these irradiated oligonucleotides, the crystal structures
of Drosophila melanogaster (6-4) photolyase in complex with
oligonucleotides containing its natural substrates T(6-4)T and
T(6-4)C were obtained (Fig. 2).39,41 These structures provide
support for a mechanism without rearrangement of the (6-4)
lesions to strained four-membered ring intermediates and
argues for a direct electron injection into the lesion as the
initial step of repair performed by (6-4) DNA photolyases.42
The use of irradiated oligonucleotides was also successfully
used for the production of unnatural (6-4) lesions. Carell and
coworkers showed that the use of N(4)-methylcytosine (C*) in
thymidylyl(30–50)cytidine sequences results in T(6-4)C* lesions
with amazingly low repair rates, with a surprising scientific
outcome.43 During repair of T(Dew)C*, bearing the exocyclic
–NHMe group, the low turnover of the corresponding (6-4)
lesion leads to accumulation of it as an intermediate in the
repair reaction. Further experiments with oxidized FAD
indicate that this rearrangement requires electron injection.
Therefore it was shown that (6-4) photolyases repair Dewar
valence isomers by electron driven isomerisation to (6-4)
lesions.43
4. The spore photoproduct
The previously mentioned spore photoproduct (SP),
discovered in 1965 by Donnellan and Setlow, is in many
aspects different to the CPD, (6-4) and Dewar lesions.5
However, the SP is not formed via an electrocyclic reaction
and is uniquely found in spores, where it is the predominant
lesion and only exists as T(SP)T. Formation, synthesis and
repair of the lesion have been recently reviewed and therefore
only key issues will be presented here.14
Begley and coworkers developed the first total synthesis of
5-(a-thyminyl)-5,6-dihydrothymine (see Scheme 6).44 The key
step of this synthesis is the enol coupling of the allylbromide 27
and the 5,6-dihydrothymidine 28. In this step 27 is lithiated
with LDA, then added to 28, followed by removal of the TES
groups with HF in acetonitrile to afford 29 as a diastereotopic
mixture. After treatment with DMTCl to protect the 50-OH
group, 2-chlorophenyl-dichlorophosphate together with 1,2,
4-triazole was used to yield the protected phosphate 30.
TBAF deprotection and 1-(mesitylene-2-sulfonyl)-3-nitro-
1,2,4-triazole mediated ring closing in pyridine furnished the
phosphotriester linked dinucleotide. Treatment with SnCl4
simultaneously cleaved the SEM and DMT groups to give
31, which was finally deprotected with NH4OH to afford the
two diastereomers 32 and 33 after HPLC separation.
Solid phase synthesis of DNA containing a SP analogue with
an open backbone has been recently published.45 The key step
is again an enol coupling between a dihydrothymidine and an
allylbromide, whereas the choice of protecting groups is
different in order to replace the internal phosphate by two
TBDPS groups. A three step protocol was used to obtain
oligonucleotides containing the SP analogue after solid phase
synthesis with the corresponding phosphoramidite. Removal
Fig. 2 The active site structure of the (6-4) photolyase. The FAD is
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of the N(3)-SEM groups was achieved by treatment of the
DNA strand with 1 M SnCl4 in THF on the solid support,
followed by cleavage from the support and removal of the
TBDPS groups with TBAF.
For enzymatic assays the SP-containing DNA and the SP
dinucleotide are normally produced via irradiation of dried oligo-
nucleotides together with dipicolinic acid (DPA).5,14,16,46–49 How-
ever, in order to obtain defined nucleotide sequences, necessary for
many applications such as crystallization, this method is limited to
short oligonucleotides and the yields are very unsatisfactory.
Nicholson and coworkers used such oligonucleotides to
investigate the binding mode of spore photoproduct lyase.50
The SP containing DNA shows enhanced digestion byDNase I
if SP lyase is added. These data suggest that SP lyase causes a
significant bending or distortion of the DNA helix such as base
flipping in the vicinity of the lesion.
The mode of repair of the spore photoproduct by SP lyase is
still unclear and even the question of which diastereoisomer is
finally accepted as a substrate has not been fully clarified.51–53
Indeed, a mechanism has been proposed and is supported by
experiments such as mutation studies on SP lyase, but structural
information such as crystal structures is still lacking.54,55
5. Conclusions
Investigation of nature’s mechanisms of photolesion
recognition, tolerance and repair is limited and directly
linked to the availability of lesion-containing DNA.
Currently this availability varies considerably and is highly
dependent on the type of lesion. For instance, CPD building
blocks for solid phase synthesis of DNA are state of the art and
commercially accessible, thus making this lesion the best
understood example of UV induced DNA damage. In
contrast, generation of (6-4) and Dewar lesion bearing
oligonucleotides is still a challenging task. The synthesis of
building blocks suitable for solid phase synthesis is long with
unsatisfying yields, whereas direct irradiation techniques are
limited to special sequences and relatively short oligo-
nucleotides. Moreover, an efficient route to SP containing
DNA with defined sequence and length is still missing.
Direct irradiation protocols suffer from very low yields,
complicated purification and limitation to very short
oligonucleotides. No synthesis of a phosphoramidite building
block of the natural SP is available yet. Only a SP analogue
with an open backbone can be obtained, the synthesis of which
is time-consuming, not stereoselective and therefore requiring
the separation of diastereomers.
Thus, while the atomic details of the recognition and
light-driven repair of CPD and 6-4 lesions are known,
knowledge on the mechanism and function of the light-
independent SP lyase are only rudimentary. SP repair
together with the more general tolerance mechanisms TLS
and NER seem to be the main subjects of further
investigation into UV lesion repair.
Scheme 6 (a) LDA, THF, 78 1C–0 1C; (b) 4% HF in MeCN; (c) DMTCl, TEA, pyridine; (d) 2-chlorophenyl-dichlorophosphate, 1,2,4-triazole,
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